A biomarker of aging, p16, predicts peripheral neuropathy in women receiving adjuvant taxanes for breast cancer

Natalia Mitin, Kirsten A. Nyrop, Susan L. Strum, Anne Knecht, Lisa A Carey, Katherine E. Reeder-Hayes, E. Claire Dees, Trevor A. Jolly, Gretchen G. Kimmick, Meghan S. Karuturi, Raquel E. Reinbolt, JoEllen C. Speca, Erin A. O’Hare, Hyman B. Muss
doi: https://doi.org/10.1101/2022.02.10.22270086

Article usage

Article usage: February 2022 to December 2024

AbstractFullPdf
Feb 20225312187
Mar 2022146625
Apr 2022911424
May 2022114316
Jun 202290013
Jul 20225723
Aug 202274118
Sep 202287016
Oct 20224718
Nov 20223919
Dec 20223014
Jan 202329212
Feb 20232018
Mar 20232826
Apr 20232719
May 20231114
Jun 20231653
Jul 20231415
Aug 2023321312
Sep 20236344
Oct 2023815
Nov 20231868
Dec 20231726
Jan 202431210
Feb 20241746
Mar 20241015
Apr 2024957
May 2024907
Jun 20241847
Jul 20241948
Aug 20241588
Sep 20241716
Oct 2024765
Nov 20241129
Dec 2024513
Back to top
Posted February 14, 2022.
Download PDF

Supplementary Material

Data/Code
Email
A biomarker of aging, p16, predicts peripheral neuropathy in women receiving adjuvant taxanes for breast cancer
Natalia Mitin, Kirsten A. Nyrop, Susan L. Strum, Anne Knecht, Lisa A Carey, Katherine E. Reeder-Hayes, E. Claire Dees, Trevor A. Jolly, Gretchen G. Kimmick, Meghan S. Karuturi, Raquel E. Reinbolt, JoEllen C. Speca, Erin A. O’Hare, Hyman B. Muss
medRxiv 2022.02.10.22270086; doi: https://doi.org/10.1101/2022.02.10.22270086
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area